Javascript must be enabled to continue!
EVALUATION OF CIPROFLOXACIN AND CEFTRIAXONE’S EFFICACY IN THE TREATMENT OF GONORRHOEA
View through CrossRef
INTRODUCTION: A very infectious bacterial illness that may infect both men and women via sexual contact isgonorrhea, a serious public health hazard. It is among the most ancient sexually transmitted infections (STDs), andNeisseria is the cause. Rarely, gonorrhea may also result in pharyngeal, ocular, articular, and dermatological conditionsin addition to its predominant urogenital signs and symptoms. Gonorrhea has been treated with various antibiotics,including spectinomycin, cephalosporins, tetracyclines, macrolides, sulpha medicines, and fluoroquinolones. Some ofthese medications are no longer used to treat gonorrhea due to an increase in resistant infections.OBJECTIVE: This research compared the efficaciousness of Ceftriaxone and ciprofloxacin in managing gonococcalinfections.STUDY DESIGN: A- Observational- StudyPlace And Duration of Study: The study was conducted in New Gulail Polyclinic, Saudi Arabia, from January2003 to March 2004.METHODS: With the institutional Ethical Committee’s consent, 200 patients received Ceftriaxone and ciprofloxacin to treat gonorrhea. Enrolling the patients included the use of a purposeful sampling approach. Every patientwas divided into two groups of 100 individuals, each at random. Group B received a single intravenous dose of 500mg of Ceftriaxone Injection, whereas Group A received a 500 mg tablet of Ciprofloxacin. After five days, all of thepatients had follow-up examinations, and their lab and clinical test results were documented and evaluated.RESULTS: Patients in Group A (n=100) receiving ciprofloxacin demonstrated 80% full response, 9% partialresponse, and 11% showed no improvement on the fifth day after therapy. On the other hand, patients taking ceftriaxonein Group B (n=100) had 90% complete responses, 4% partial responses, and 6% no responses at all.To sum up, Ceftriaxone treated gonorrhea more well than ciprofloxacin. It is recommended that all patients get afollow-up examination to confirm the whole course of therapy for gonorrhea after taking a single antibiotic dosage.KEYWORDS: Neisseria gonorrhea, sexually transmitted infection (STI), Sexually Transmitted Disease (STD)
Bacha Khan Medical College
Title: EVALUATION OF CIPROFLOXACIN AND CEFTRIAXONE’S EFFICACY IN THE TREATMENT OF GONORRHOEA
Description:
INTRODUCTION: A very infectious bacterial illness that may infect both men and women via sexual contact isgonorrhea, a serious public health hazard.
It is among the most ancient sexually transmitted infections (STDs), andNeisseria is the cause.
Rarely, gonorrhea may also result in pharyngeal, ocular, articular, and dermatological conditionsin addition to its predominant urogenital signs and symptoms.
Gonorrhea has been treated with various antibiotics,including spectinomycin, cephalosporins, tetracyclines, macrolides, sulpha medicines, and fluoroquinolones.
Some ofthese medications are no longer used to treat gonorrhea due to an increase in resistant infections.
OBJECTIVE: This research compared the efficaciousness of Ceftriaxone and ciprofloxacin in managing gonococcalinfections.
STUDY DESIGN: A- Observational- StudyPlace And Duration of Study: The study was conducted in New Gulail Polyclinic, Saudi Arabia, from January2003 to March 2004.
METHODS: With the institutional Ethical Committee’s consent, 200 patients received Ceftriaxone and ciprofloxacin to treat gonorrhea.
Enrolling the patients included the use of a purposeful sampling approach.
Every patientwas divided into two groups of 100 individuals, each at random.
Group B received a single intravenous dose of 500mg of Ceftriaxone Injection, whereas Group A received a 500 mg tablet of Ciprofloxacin.
After five days, all of thepatients had follow-up examinations, and their lab and clinical test results were documented and evaluated.
RESULTS: Patients in Group A (n=100) receiving ciprofloxacin demonstrated 80% full response, 9% partialresponse, and 11% showed no improvement on the fifth day after therapy.
On the other hand, patients taking ceftriaxonein Group B (n=100) had 90% complete responses, 4% partial responses, and 6% no responses at all.
To sum up, Ceftriaxone treated gonorrhea more well than ciprofloxacin.
It is recommended that all patients get afollow-up examination to confirm the whole course of therapy for gonorrhea after taking a single antibiotic dosage.
KEYWORDS: Neisseria gonorrhea, sexually transmitted infection (STI), Sexually Transmitted Disease (STD).
Related Results
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Introduction: Gonorrhoea is a disease associated with humans and caused by N. gonorrhoea. N. gonorrhoea’s ability to evolve and evade various treatment regimens can lead to untreat...
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
Gonorrhoea is a major public health concern globally. Of particularly grave concern is that resistance to the extended-spectrum cephalosporins has emerged during the most recent ye...
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Abstract
Background: Access to ceftriaxone is still low, causing 11% of patients not to complete their treatment at health facilities in Uganda; which could increase antimi...
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Gonorrhoea is a disease associated with humans and it is caused by N. gonorrhoea. N. gonorrhoea’s ability to evolve and evade various treatment regimens can lead to untreatable Gon...
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antibiotic resistance amongst bacterial pathogens is a crisis that has been worsening over recent decades, resulting in serious and often fatal infections that cannot be treated by...
850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
Abstract
Background
MSSA is a leading cause of bloodstream infection (BSI) and its incidence is on the rise. Standard of care (S...
Prevalence and Characteristics of Ceftriaxone-Resistant Salmonella in Children’s Hospital in Hangzhou, China
Prevalence and Characteristics of Ceftriaxone-Resistant Salmonella in Children’s Hospital in Hangzhou, China
The non-Typhi Salmonella (NTS) infection is critical to children’s health, and the ceftriaxone is the important empirical treatment choice. With the increase resistance rate of cef...
Modelling treatment effects for gonorrhoea
Modelling treatment effects for gonorrhoea
Abstract
Neisseria gonorrhoeae
(NG) bacteria have evolved resistance to many of the antibiotics that have been used successfull...

